SB

Stephane Boissel

Europe, Ile-de-France, France, Paris

Description

Stephane Boissel is the Chairman and Chief Executive Officer of SparingVision. He attended the The University of Chicago Booth School of Bus...

Investor Profile

Stephane Boissel has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • France (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Which angels does Stephane Boissel often collaborate with?

DL
North America, California, United States
Shared Deals: 1

What are some of recent deals done by Stephane Boissel?

EG 427

Paris, Ile-de-France, France

EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.

BiotechnologyGeneticsTherapeutics
Series AMar 1, 2021
Amount Raised: $14,458,441